Feider Stephen sold BBNX
January 2, 2026 · Form 4 insider transaction
Feider Stephen sold 20,000 shares of Beta Bionics, Inc. at $29.53 per share, a transaction worth $590.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
20,000
Price
$29.53
Total value
$590.7K
InsiderFeider Stephen
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after42,614
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.; The weighted average sale price for the transaction reported was $29.534002 and the range of prices were between $29.09 and $30.06. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.